Zhitong Finance App News, Goli Pharmaceutical-B (01672.HK) issued an announcement that it intends to exercise its power to repurchase shares on the open market at an appropriate time in accordance with the general authorization granted by the company's shareholders to the board of directors to buy back the company's shares at the company's annual general meeting of shareholders to be held on May 22, 2025. According to the repurchase authorization, the company was authorized to repurchase up to 96.284,600 shares, equivalent to 10% of the total number of shares issued on the date of the annual shareholders' meeting (excluding treasury shares).

Zhitong Finance App News, Goli Pharmaceutical-B (01672.HK) issued an announcement that it intends to exercise its power to repurchase shares on the open market at an appropriate time in accordance with the general authorization granted by the company's shareholders to the board of directors to buy back the company's shares at the company's annual general meeting of shareholders to be held on May 22, 2025. According to the repurchase authorization, the company was authorized to repurchase up to 96.284,600 shares, equivalent to 10% of the total number of shares issued on the date of the annual shareholders' meeting (excluding treasury shares).